Suresh Hanagavadi

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

Flora Peyvandi, Pier Mannuccio Mannucci, Isabella Garagiola et al. · New England Journal of Medicine · 2016 · 491 citations · Full text

Medicine, Hematology, Immunology +16

Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis

Flora Peyvandi, Antonino Cannavò, Isabella Garagiola et al. · Journal of Thrombosis and Haemostasis · 2017 · 40 citations · Full text

Medicine, Pharmacokinetics, Clinical Pharmacology +13

Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement

Silvia Spena, Isabella Garagiola, Antonino Cannavò et al. · Journal of Thrombosis and Haemostasis · 2018 · 32 citations · Full text

Medicine, Hematology, Molecular Medicine +14

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Flora Peyvandi, Pier Mannuccio Mannucci, Isabella Garagiola et al. · Blood · 2015 · 21 citations

Medicine, Hematology, Hemostasis +15

Comparative analysis of oral health and treatment necessities in hemophilia individuals of Davangere population — A case control study

Varsha Kanjani, RajeshwariG Annigeri, Suresh Hanagavadi et al. · Journal of Family Medicine and Primary Care · 2020 · 13 citations · Full text

Dentistry, Dental Hygiene, Oral Health Sciences +16